Detecting Rare ALK Gene Fusions in Unclassified Spindle Cell Lung Tumors Using Anchored Multiplex PCR/Targeted RNA Next-Generation Sequencing.
Summary
This study investigated oncogenic fusions in 11 unclassified pulmonary spindle cell tumors, aggressive neoplasms with limited treatment options. Using anchored multiplex PCR-based targeted RNA sequencing, researchers identified ALK gene fusions in two patients (18.2%), specifically PPFIBP1::ALK and SYCL3::ALK. Both tumors also exhibited positive ALK immunohistochemical staining, despite showing morphological heterogeneity. These findings expand the molecular spectrum of these rare tumors and highlight the importance of detecting ALK fusions, including those with uncommon partners.
Analysis
This research is crucial because pulmonary spindle cell tumors are often aggressive and challenging to treat. The identification of ALK fusions, even rare ones and with atypical partners, paves the way for potentially effective targeted therapies for these patients. The study validates the combined use of ALK immunohistochemistry as a screening tool and anchored multiplex PCR-based RNA sequencing for precise detection, which could refine diagnosis and guide therapeutic decisions in these complex cases.